T. Christopher Mast

3.3k total citations · 1 hit paper
57 papers, 2.6k citations indexed

About

T. Christopher Mast is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, T. Christopher Mast has authored 57 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 17 papers in Cardiology and Cardiovascular Medicine and 16 papers in Epidemiology. Recurrent topics in T. Christopher Mast's work include Viral gastroenteritis research and epidemiology (31 papers), Viral Infections and Immunology Research (17 papers) and Hepatitis Viruses Studies and Epidemiology (16 papers). T. Christopher Mast is often cited by papers focused on Viral gastroenteritis research and epidemiology (31 papers), Viral Infections and Immunology Research (17 papers) and Hepatitis Viruses Studies and Epidemiology (16 papers). T. Christopher Mast collaborates with scholars based in United States, Hong Kong and Japan. T. Christopher Mast's co-authors include John D. Seeger, Swati B. Gupta, Florence T. Wang, Michelle G. Goveia, Jeanne Loughlin, Monica Reynolds, Brian R. Murphy, Joakim Dillner, Yi Pang and John T. Schiller and has published in prestigious journals such as Journal of Clinical Investigation, JNCI Journal of the National Cancer Institute and PEDIATRICS.

In The Last Decade

T. Christopher Mast

56 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

2016 295 citations T. Christopher Mast, Keith R. Jerome et al. profile →

Peers

T. Christopher Mast

EPIDE

HEPAT

CCM

SURGE

C. Y. William Tong United Kingdom

Sue Ann Costa Clemens Italy

Kristine Macartney Australia

P Morgan-Capner United Kingdom

Antonio Piralla Italy

Barry D. Schoub South Africa

Aisha O. Jumaan United States

James P. Alexander United States

Rory Gunson United Kingdom

Peter Muir United Kingdom

C. Y. William Tong United Kingdom

T. Christopher Mast

1.3k ×0.9

1.6k ×1.4

EPIDE

416 ×0.8

HEPAT

627 ×1.3

CCM

191 ×0.6

SURGE

Citations per year, relative to T. Christopher Mast T. Christopher Mast (= 1×) peers C. Y. William Tong

Countries citing papers authored by T. Christopher Mast

Since Specialization

Citations

This map shows the geographic impact of T. Christopher Mast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Christopher Mast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Christopher Mast more than expected).

Fields of papers citing papers by T. Christopher Mast

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Christopher Mast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Christopher Mast. The network helps show where T. Christopher Mast may publish in the future.

Co-authorship network of co-authors of T. Christopher Mast

This figure shows the co-authorship network connecting the top 25 collaborators of T. Christopher Mast. A scholar is included among the top collaborators of T. Christopher Mast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Christopher Mast. T. Christopher Mast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mast, T. Christopher, et al.. (2024). Benefit–risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373). Vaccine. 42(9). 2161–2165. 1 indexed citations

Duke, Elizabeth R., Brian D. Williamson, Bhavesh Borate, et al.. (2020). CMV viral load kinetics as surrogate endpoints after allogeneic transplantation. Journal of Clinical Investigation. 131(1). 40 indexed citations

Escobar, Gabriel J., Jennifer M. Baker, Patricia Kipnis, et al.. (2017). Prediction of RecurrentClostridium DifficileInfection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System. Infection Control and Hospital Epidemiology. 38(10). 1196–1203. 35 indexed citations

Desai, Kamal, Swati B. Gupta, Erik R. Dubberke, et al.. (2016). Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. BMC Infectious Diseases. 16(1). 303–303. 132 indexed citations

Gupta, Swati B., Vinay Mehta, Erik R. Dubberke, et al.. (2016). Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence. Clinical Infectious Diseases. 63(6). 730–734. 55 indexed citations

Mast, T. Christopher, et al.. (2015). Evidence of Herd Immunity and Sustained Impact of Rotavirus Vaccination on the Reduction of Rotavirus-Related Medical Encounters Among Infants from 2006 through 2011 in the United States. The Pediatric Infectious Disease Journal. 34(6). 615–620. 27 indexed citations

Quinlan, Scott, Stephan Lanes, Crystal N. Holick, & T. Christopher Mast. (2015). Accuracy of administrative claims data to identify dose specific rotavirus vaccination information: Implications for studies of vaccine safety. Vaccine. 33(22). 2517–2520. 1 indexed citations

Lanes, Stephan, Scott Quinlan, T. Christopher Mast, Sander Greenland, & Crystal N. Holick. (2015). Assessing bias in administrative database studies of RotaTeq vaccine completion due to exclusion of subjects with incomplete follow-up. Emerging Themes in Epidemiology. 12(1). 5–5. 7 indexed citations

Norquist, Josephine M., T. Christopher Mast, Kai‐Li Liaw, et al.. (2012). Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance. Human Vaccines & Immunotherapeutics. 8(9). 1208–1212. 16 indexed citations

10.

Wang, Florence T., T. Christopher Mast, Roberta Glass, Jeanne Loughlin, & John D. Seeger. (2012). Effectiveness of an Incomplete RotaTeq (RV5) Vaccination Regimen in Preventing Rotavirus Gastroenteritis in the United States. The Pediatric Infectious Disease Journal. 32(3). 278–283. 25 indexed citations

11.

Teppler, Hedy, Deborah D. Brown, Randi Y. Leavitt, et al.. (2011). Long-Term Safety from the Raltegravir Clinical Development Program. Current HIV Research. 9(1). 40–53. 30 indexed citations

12.

Eng, Patricia Mona, et al.. (2011). Incidence of Intussusception Among Infants in a Large Commercially Insured Population in the United States. The Pediatric Infectious Disease Journal. 31(3). 287–291. 17 indexed citations

13.

Staat, Mary Allen, Stephanie Donauer, Daniel C. Payne, et al.. (2010). Estimating the Rotavirus Hospitalization Disease Burden and Trends, Using Capture-recapture Methods. The Pediatric Infectious Disease Journal. 29(12). 1083–1087. 15 indexed citations

14.

Wang, Kung‐Liahng, Cherng‐Jye Jeng, Yuh‐Cheng Yang, et al.. (2010). The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions. Journal of Psychosomatic Obstetrics & Gynecology. 31(1). 16–23. 47 indexed citations

15.

Mast, T. Christopher, et al.. (2010). Burden of Childhood Rotavirus Disease on Health Systems in the United States. The Pediatric Infectious Disease Journal. 29(2). e19–e25. 39 indexed citations

16.

Mast, T. Christopher. (2009). US Post-Licensure Active Surveillance Safety Study of RotaTeq™, Oral Pentavalent Rotavirus Vaccine (RV5). 1 indexed citations

17.

Mast, T. Christopher, et al.. (2009). The impact of rotavirus gastroenteritis on the family. BMC Pediatrics. 9(1). 11–11. 55 indexed citations

18.

Mast, T. Christopher. (2008). Post-Licensure Effectiveness of RotaTeq ® in Preventing Gastroenteritis. 46th Annual Meeting. 10 indexed citations

19.

Harro, Clayton, Yi Pang, Richard B.S. Roden, et al.. (2001). Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine. JNCI Journal of the National Cancer Institute. 93(4). 284–292. 454 indexed citations

20.

Vasudevachari, M. B., T. Christopher Mast, & Norman P. Salzman. (1990). Suppression of HIV-1 Reverse Transcriptase Activity by Mycoplasma Contamination of Cell Cultures. AIDS Research and Human Retroviruses. 6(3). 411–416. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact